Bionano Symposium 2026 continues with Day 2: New Frontiers in Oncology and Bioprocessing Applications on February 24, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

Kymera Therapeutics develops targeted protein degradation therapies for immunology, oncology, and fibrosis using proprietary ...

Arcellx develops next-generation cell therapies targeting multiple myeloma and other hematologic cancers in the biotechnology sector.

A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled "CAR-T therapy: Trailblazing CAR(ing) in cancer treatment." ...

Oluwasegun Akinyemi, MD, PhD, MSc, expressed concern about recent cuts and potential threats to Medicaid expansion. Previous ...

The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic colorectal cancer.Encorafenib (Braftovi, Pfizer) plus cetuximab (Erbitux, ...

While not every patient with AML develops skin involvement, it can be one of the earliest visible signs that something systemic is occurring.

Citi's 2026 Virtual Oncology Leadership Summit February 19, 2026 10:00 AM ESTCompany ParticipantsNadim Ahmed - ...

By Dr. Priyom Bose, Ph.D. For many patients, the emotional toll of cancer can become a hidden risk factor, one that may influence survival as much as the disease itself. Study: Association of mental ...

A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.

Rare tumors, although individually uncommon, collectively account for a considerable proportion of cancer diagnoses and pose unique clinical and biological ...

Bone marrow transplant (BMT) can be a life-saving procedure for children diagnosed with cancers and serious blood disorders. But how should families prepare? What physical, emotional, and ...